Letter--Prudent Formulary Management or Underutilization of the Novel P2Y12 Receptor Inhibitors in Patients with Acute Coronary Syndrome Who Received Percutaneous Coronary Intervention?
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.